|
000
| 01626cas 2200313za 4500 |
|---|
| 001 | 9.506080 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240216152511 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406c19969999oncar p o f0 a0eng|d |
|---|
| 022 | |a1495-0561 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH78E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 210 | 0 |aAnnu. rep. - Can., Pat. Med. Prices Rev. Board |b(Online) |
|---|
| 222 | 0|aAnnual report - Canada. Patented Medicine Prices Review Board |b(Online) |
|---|
| 245 | 10|aAnnual report |h[electronic resource] / |cPatented Medicine Prices Review Board. |
|---|
| 246 | 13|aPMPRB annual report |
|---|
| 260 | |a[Ottawa] : |bPatented Medicine Prices Review Board, |c[199-]- |
|---|
| 310 | |aAnnual |
|---|
| 362 | 0 |a9th (1996)- |
|---|
| 500 | |aIssued also in French under title: Rapport annuel / Conseil d'examen du prix des médicaments brevetés. |
|---|
| 520 | 3 |aAn independent, quasi-judicial body, Canada’s Patented Medicine Prices Review Board (PMPRB) regulates the prices of prescription and non-prescription patented drugs for human and veterinary use, ensuring that these prices are not excessive. This report includes a review of the PMPRB’s major activities, as well as analyses of the prices of patented medicines and of the price trends of all drugs. It also lists the R&D expenditures reported by patent-holding drug manufacturers. |
|---|
| 692 | 07|2gccst|aDrugs |
|---|
| 692 | 07|2gccst|aPatents |
|---|
| 775 | 08|tRapport annuel |w(CaOODSP)9.502482 |
|---|
| 776 | 0#|tPatented Medicine Prices Review Board annual report |w(CaOODSP)9.512094 |
|---|